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bstract
Mixed neuronal and glial cell spinal cord cultures from neonates express ADP sensitive P2Y1,12&13 receptors. ADP (10M) evoked increases in
ntracellular calcium that were essentially abolished by the P2Y1 receptor antagonist MRS2179 (10M), responses were also absent in preparations
rom P2Y1 receptor deficient mice however UTP (100M) evoked calcium rises were unaffected. ADP also evoked a robust increase in extracellular
ignal-regulated protein kinase (ERK) phosphorylation that was of similar magnitude in the cultures from wild type and P2Y1 receptor deficient
ice. These results suggest that ADP acts through P2Y1 receptors to mediate an increase in intracellular calcium but not to stimulate ERK
hosphorylation in the spinal cord.
 2008 Elsevier Ireland Ltd. 
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ucleotides released from neurons, glia and damaged cells play
signalling role in the nervous system. P2Y receptors are a fam-
ly of G-protein coupled nucleotide receptors, and several of the
ight subtypes (P2Y1,2,4,6,11,12,13,14) are expressed in the nervous
ystem [11]. P2Y1 receptors have been shown to be involved in
alcium signalling in a range of neurons and glial cells (e.g.
3,4,9,12]). In addition signalling through recombinant P2Y1
eceptors stimulates mitogen-activated (MAP) kinases [10] and
n native cells P2Y1 receptors have been implicated to play a
ole in extracellular signal related kinases (ERK) activation and
tretch induced injury in astrocytes [8]. In this study the aim was
o determine whether ADP evoked calcium and MAP kinase
esponses in cultured spinal cord neurons and glial cells and use
nockout mice to determine the contribution of P2Y1 receptors
o ADP evoked signalling.
Wild type or P2Y1 receptor deficient C57 neonatal mice [7]
3–7 days) of either sex were decapitated and the spinal column
as removed and washed twice in a calcium/magnesium-
ree Hanks balanced salt solution (HBSS) containing HEPES
0.3 M), sodium pyruvate and penicillin/streptomycin (50g/ml
∗ Corresponding author. Fax: +44 116 252 5045.
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ach). The spinal cord was then cut into small pieces and placed
n ice cold HBSS. The tissue pieces were then placed in a HBSS-
rypsin solution (2.5%) and incubated at 37 ◦C for 30 min. The
issue was then transferred to a HBSS-trypsin inhibitor solution
1 mg/ml) for 5 min before being replaced with 1 ml Neurobasal
edia containing glutamine and B27 supplement. Mechanical
rituration was used to dissociate the spinal cord cells. The result-
ng cell suspension was seeded onto poly-d-lysine-coated 16 mm
overslips and maintained at 37 ◦C in a humidified incubator
ith a 95% O2/5% CO2 atmosphere. After 2 h an additional
ml of Neurobasal media was added and cells left to grow for
–5 days.
Spinal cord cultures were ester loaded with a calcium
ensitive dye, Fluo-3 acetoxymethyl ester (Fluo-3-AM, final
oncentration 1M) for 30 min at 37 ◦C in a humidified incuba-
or. The coverslips were then washed in extracellular solution
in mM; 150 NaCl, 10 HEPES, 10 Glucose, 2.5 KCl, 2.5
aCl2, 1 MgCl2, pH 7.3) to remove any extracellular dye
nd maintained at room temperature. Coverslips were mounted
n a perfusion chamber on the stage of a Fluoview FV300
onfocal microscope and were continuously perfused with extra-
ellular solution. The argon laser excitation of the dye was
t 488 nm and the emissions were captured at wavelengths
reater than 510 nm by Olympus Fluoview v4.2 software at
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cells from 4 coverslips). We have previously used calcium imag-
ing to look at P2Y receptor signalling in mouse superior cervical
ganglia [1] and similar protocols were used in this study. ADP
(10M) evoked robust increases in intracellular calcium for
Fig. 1. Effects of the P2Y1 receptor antagonist MRS2179 on ADP evoked
calcium responses from spinal cord co-cultures. (A) Example traces from an
individual neuron to ADP (10M) and application of MRS2179 (1 and 10M)
and following washout of the antagonist. (B) Example traces from an individualA.E. Atterbury-Thomas et al. / Neu
frequency of 0.5 Hz for a continuous time period of 280 s.
gonist application was via a U-tube [2]. ADP stocks were
reated with hexokinase to remove any ATP contamination.
gonist applications were at intervals of ∼10 min. Antago-
ists were perfused for 8 min before test solution application
o as to allow complete equilibration. Cells displaying ‘puff’
rtefacts to just extracellular solution were discounted from
nalysis [1]. Baseline measurements of fluorescence were cal-
ulated as a mean of the 10 s of recording prior to agonist
pplication. Peak changes in fluorescence for neuronal and
lial cells were expressed as a ratio of the baseline (increases
n fluorescence are expressed as a self-ratio, baseline value is
).
Spinal cord cells were cultured for 2–5 days as described
reviously and agonists were applied to individual wells and
ncubated for 10 min. The cells were subsequently lysed in a
olution (in mM; 10 -glycerophosphate, 1 EDTA, 1 EGTA,
0 Tris–HCl, 1 benzamidine, 1 sodium orthovanadate, 0.2
MSF, 50 sodium fluoride, 1 mg/ml pepstatin A, 1 mg/ml
eupeptin, 0.1% -mercaptoethanol, 1% Triton X-100). The
amples were then mixed with sodium dodecyl sulphate sam-
le buffer (containining -mercaptoethanol) at a ratio of 1:1
nd denatured for 5 min at 95 ◦C prior to loading on a 10%
odium dodecyl sulphate polyacrylamide gel. The protein was
hen transferred onto a nitrocellulose membrane and subse-
uently blocked with blocking medium (5% non-fat milk powder
nd Tris-Tween 20, buffered salts-TTBS) overnight at 4 ◦C.
itrocellulose membranes were then incubated in 5% block-
ng medium containing either anti-phospho-ERK antibody (Cell
ignaling Technology, MA, USA) at a dilution of 1:1000 or
nti-non-phosphorylated ERK antibody (Cell Signaling Tech-
ology, MA, USA) at a dilution 1:1000. Immunoreactive bands
ere visualised by incubation of nitrocellulose membranes with
nti rabbit peroxidase conjugate at 1:1500 for 2 h at room
emperature and then detected with chemiluminiscence (ECL
lus, Amersham, UK) and recorded onto hyperfilm (Amer-
ham, UK). Western blots were analysed using Image J, NIH,
SA—http://rsb.info.nih.gov. Phospho ERK intensity was cor-
ected for loading using non-phosphorylated ERK blotting and
xpressed as fold over basal.
Total RNA was isolated from either intact spinal cord or spinal
ord using the RNeasy Mini Kit (QIAGEN, Valencia, CA). The
NA was treated with DNase I (Sigma) to remove any DNA
ontamination. Half of the purified RNA was reverse-transcribed
o cDNA using SuperScript II-reverse transcriptase (Invitrogen,
arlsbad, CA), and the remainder of the RNA was used as a
egative control to ensure that there was no genomic contam-
nation. The primers have been described previously [1]. PCR
eactions were carried out with 2l of cDNA and a final con-
entration of 500 nM of each primer. Amplification took place
n a Techne Genius PCR machine (Techne, Cambridge, UK)
sing the following protocol: denaturation at 94 ◦C for 5 min;
epeated cycles of denaturation at 94 ◦C, followed by annealing
t 57 ◦C and extension at 72 ◦C, each for 30 s; final extension at
2 ◦C for 10 min. Thirty-five cycles were used. The amplifica-
ion products were examined by electrophoresis on a 1% agarose
el and visualized using ethidium bromide under UV light.
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Statistical tests were preformed using an unpaired t-test with
p-value of <0.05 considered as significant. Data are expressed
s mean ± standard error of the mean.
Spinal cord cells cultured from neonates for 3–7 days con-
ained both neuronal and glial cells that could be distinguished
y their morphology and staining with glial fibrillary acidic pro-
ein; approx 43% of cells were glia and 57% neuronal (n = 576lial cell to ADP (10M) and application of MRS2179 (1 and 10M) and fol-
owing washout of the antagonist. Summary of effects of MRS2179 on neurons
C) and glial cells (D). Data are expressed as the F510 self-ratio (F510 S-R) of
alcium increase compared to basal levels (self-ratio of 1). Drug applications
re indicated by bar, n = 38 neurons and 45 glial cells.
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of the P2Y11 receptor has not been detected suggesting that92 A.E. Atterbury-Thomas et al. / N
oth neurons (64% cells responding with peak self-ratio ampli-
ude of 2.20 ± 0.14, n = 120 cells from 12 coverslips) and glial
ells (57% of cells responded with a peak self-ratio amplitude
f 2.17 ± 0.2, n = 120 cells from 12 coverslips). Responses were
ot sustained and generally decayed during the time-course of
pplication (self-ratio at end of 30 s application 1.34 ± 0.08 and
.27 ± 0.04 for neurons and glia, respectively, n = 20 for each).
The selective P2Y1 receptor antagonist MRS2179 reduced
DP evoked calcium rises in a concentration-dependent manner
nd these effects were reversed on antagonist washout (Fig. 1).
DP evoked calcium rises were essentially abolished in spinal
ord cultures from P2Y1 receptor deficient mice with small
esidual responses in 11% of neurons (self-ratio 1.14 ± 0.05,
= 100 cells from 10 coverslips) and 17% of glial cells (self-ratio
.21 ± 0.05, n = 115 cells from 11 coverslips)(Fig. 2). Responses
o the P2Y2/4 receptor agonist UTP (100M) in cultures from
2Y1 receptor deficient mice were the same as for WT for neu-
ons (45 and 48% responding with amplitudes of 1.96 ± 0.09
nd 1.79 ± 0.08, n = 60, 114 from 6 and 12 coverslips, respec-
ively for WT and P2Y1 receptor deficient mice) and glial cells
58 and 62% responding with amplitudes of 1.88 ± 0.13 and
.67 ± 0.04, n = 60, 119 from 6 to 12 coverslips, respectively
or WT and P2Y1 receptor deficient mice) indicating that Gq
oupled receptor calcium signalling was not affected in the
2Y1 receptor deficient mouse (Fig. 2). Taken together these
esults define a role of the P2Y1 receptor in calcium signalling
n spinal cord neurons and glial cells. These studies support the
ole of P2Y1 receptors in calcium signalling in the nervous sys-
ig. 2. ADP evoked calcium signalling is abolished in spinal cord cultures from
2Y1 receptor deficient mice. Sample traces of neuronal responses to UTP
100M) and ADP (10M) from wild type (WT) (A) and P2Y1 receptor defi-
ient mice (B). Sample traces of glial cell responses to UTP (100M) and ADP
10M) from wild type (WT) (C) and P2Y1 receptor deficient mice (D). Data
re expressed as the F510 self-ratio (F510 S-R) of calcium increase compared to
asal levels (self-ratio of 1). Drug application indicated by bar.
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em [3,9,12] and corroborate previous studies using sympathetic
anglion cultures from the P2Y1 receptor deficient mouse [1].
P2Y1 receptor stimulation has also been reported to mediate
RK phosphorylation in recombinant [10] and native systems
8] and this may contribute to changes in the spinal cord follow-
ng injury. In spinal cord cultures ADP evoked a time-dependent
hosphorylation of p44/42 ERK that was detected at 5 min,
eaked at 10 min, and declined back to basal levels by 30 min
Fig. 3A). When just media was added to the cultures there was
o change in ERK phosphorylation (Fig. 3B) indicating that
RK stimulation does not result from a mechanical artefact.
denosine (10M) also had no effect demonstrating that adeno-
ine receptors are not involved. We therefore compared ADP
voked ERK phosphorylation in spinal cord cultures from WT
nd P2Y1 receptor deficient mice. Surprisingly ADP (10M)
voked similar levels of ERK phosphorylation (∼3-fold increase
ver basal) in WT and P2Y1 receptor deficient cultures (Fig. 3)
emonstrating that a receptor other than the P2Y1 receptor medi-
tes this ADP response.
Of the currently eight identified P2Y receptor genes ADP
s an agonist at Gq coupled P2Y1, and Gi coupled P2Y12
nd P2Y13 receptors [11]. ADP is also an agonist at the human
2Y11 receptor; however a corresponding mouse homologueice do not express P2Y11-like receptors [11]. Transcripts for
2Y1,12&13receptors were detected in 3–7 days old spinal cord
ig. 3. ADP evoked ERK phosphorylation in mouse spinal cord cultures. (A)
DP evoked a time-dependent phosphorylation of ERK p44/42 that peaked at
0 min. Non-phosphorylated p44/42 is shown as a loading control. (B) ADP
10M) evoked ERK phosphorylation is observed in spinal cord cultures from
oth WT and P2Y1 receptor deficient (KO) cultures. (C) Summary data for
RK phosphorylation (fold over basal) for cultures from WT and P2Y1 receptor
eficient mice. n = 3 for WT and n = 4 for P2Y1 receptor deficient cultures.
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ultures (data not shown). Amplification of RNA for ADP sen-
itive P2Y12&13 receptors raised the possibility that these may
ontribute to the ERK phosphorylation. AR-C66931MX [6] is
n antagonist of P2Y12 and P2Y13 receptors with a reported
A2 of 8.7 at P2Y12 receptors and 0.01M reduced ADP
esponses by ∼80% at recombinant P2Y13 receptors (see review
11]). AR-C66931MX (10M a supra-maximal concentration
t P2Y12 receptors) had no effect on ADP evoked ERK phos-
horylation indicating that P2Y12 receptors did not mediate
he ERK phosphorylation. AR-C66931MX may have complex
ctions at P2Y13 receptors, possibly dependent on cell type, and
as been described as an activator of P2Y13 receptor depen-
ent high density lipoprotein endocytosis in hepatocytes [5]
uestioning the use of this compound as a selective antago-
ist at the P2Y13 receptor. Thus it remains to be determined
hether the P2Y13 receptor, or a novel ADP sensitive receptor,
ediates the ADP evoked ERK phosphorylation in the spinal
ord.
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